Zacks Industry Outlook Highlights Aflac, Unum and Trupanion
Werte in diesem Artikel
For Immediate ReleaseChicago, IL – October 3, 2024 – Today, Zacks Equity Research discusses Aflac Inc. AFL, Unum Group UNM and Trupanion TRUP.Industry: Health InsuranceLink: https://www.zacks.com/commentary/2344832/3-stocks-to-watch-from-the-thriving-accident-health-insurance-industryThe Zacks Accident and Health Insurance industry is expected to benefit from an increase in underwriting exposure. Aflac Inc., Unum Group and Trupanion are expected to be driven by prudent underwriting standards. However, a rise in claims frequency could offset the positives.The industry has been witnessing soft pricing over the past several quarters, which is not expected to change any time soon. Nonetheless, a rise in claims, with business activities returning to normal levels, is likely to favor pricing. Also, the increasing adoption of technology in operations will help the industry to function smoothly.About the IndustryThe Zacks Accident and Health Insurance industry comprises companies providing workers’ compensation insurance, mainly to employers operating in hazardous industries. These companies offer group, individual or voluntary supplemental insurance products. Workers' compensation is a form of accident insurance paid by employers without affecting employees’ pay.Claims are generally met by insurers or state-run workers’ compensation funds, benefiting both employers and employees. While it boosts employees’ morale and, in turn, productivity, employers stand to benefit from lower claim costs. As awareness about the benefits of having such coverage rises, the future of these insurers seems bright. Per Precision Reports, the global worker's compensation insurance market is expected to grow considerably between 2024 and 2032.3 Trends Shaping the Future of the Accident & Health Insurance IndustryPricing Pressure to Continue: The worker compensation industry has been witnessing pricing pressure over the past several quarters. Inflation, coupled with rising medical costs, will likely continue to put pressure on pricing. Per a report in Commercial Risks, AM Best expects sustained favorable loss development and beneficial loss frequency to put downward pressure on pricing.Efforts to retain market share will further increase pricing pressure, which might curb top-line growth. With commercial and industrial activities back on track, insurance coverage demand is likely to rise. SpendEdge estimates that workers’ compensation insurance pricing will increase at a five-year (2022-2026) CAGR of 5.3%. Also, per a CBIZ report, workers’ compensation pricing is expected to rise 2%.Claims Frequency to Improve: Adoption of safety measures and improving working conditions are lowering claims. The accident and health insurance space has witnessed growth over the years, primarily driven by an increase in benefits offered by employers. The right kind of workers’ compensation policy translates into personal care for injured workers, increased productivity, higher employee morale, lower turnover, reduced claims costs and less financial worry amid rising medical costs.Increasing underwriting exposure, sustained decrease in claims frequency rates attributable to a better working environment and conservative reserve levels have been boosting the industry’s performance. Per U.S. Bureau of Labor Statistics data in an AmTrust Financial report, workers over the age of 55 will increase to about 25% in 2024 from 21.7% in 2014. Thus, claims could rise based on the degree of severity, the report states.Increasing Adoption of Technology: The industry is witnessing accelerated adoption of technology in operations, including artificial intelligence. Electronic applications, e-signatures, electronic policy delivery, cloud computing and blockchain should help insurers gain a competitive edge. Per a CBIZ report, industry data reveals that artificial intelligence could reduce workers’ compensation claim expense by about 45%. Nonetheless, higher spending on technological advancements will result in escalated expense ratios.Zacks Industry Rank Indicates Bright ProspectsThe group’s Zacks Industry Rank, which is basically the average of the Zacks Rank of all member stocks, indicates encouraging near-term prospects. The Zacks Accident and Health Insurance industry, housed within the broader Zacks Finance sector, currently carries a Zacks Industry Rank #103, which places it in the top 41% of the 251 Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperforms the bottom 50% by a factor of more than 2 to 1.The industry’s position in the top 50% of the Zacks-ranked industries is a result of a positive earnings outlook for the constituent companies in aggregate. Looking at the aggregate earnings estimate revisions, it appears that analysts are gradually gaining confidence in this group’s earnings growth potential. The industry’s earnings estimate for the current year has moved up 8% in a year.Before we present a few stocks one can buy or retain, given their business advancement endeavors, it’s worth taking a look at the industry’s performance and current valuation.Industry Outperforms Sector and S&P 500The Accident and Health Insurance industry has outperformed its sector and the Zacks S&P 500 composite over the past year. The stocks in this industry have collectively gained 33.6% year to date compared with the Finance sector’s increase of 15.8% and the Zacks S&P 500 composite’s increase of 21% over the same period.Current ValuationOn the basis of a trailing 12-month price-to-book (P/B), commonly used for valuing insurance stocks, the industry is currently trading at 1.93X compared with the Zacks S&P 500 composite’s 3.83X and the sector’s 8.77X.Over the past five years, the industry has traded as high as 1.93X, as low as 0.58X and at the median of 1.16X.3 Accident & Health Insurance Stocks in FocusWe are presenting one Zacks Rank #2 (Buy) stock and two Zacks Rank #3 (Hold) stocks from the Zacks Accident and Health Insurance industry. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Aflac: This Columbus, GA-based company offers voluntary supplemental health and life insurance products and operates through Aflac Japan and Aflac U.S. Its top line benefits from strategic growth investments, robust persistence rates and enhanced productivity. Aflac brings new products and upgrades existing ones to address the changing needs of its customers as well as integrates digital solutions into its offerings to align with the ongoing trend of digitization.These, in turn, should support strong profit margins. The Argus buyout will provide it with a platform to build the company’s network of dental and vision products and further strengthen its U.S. segment. It carries a Zacks Rank #2 currently.AFL delivered a trailing four-quarter earnings surprise of 8.24% on average. The Zacks Consensus Estimate for 2024 and 2025 earnings indicates an 8.4 % and a 5.1% year-over-year increase, respectively. The expected long-term earnings growth is 6.3%. The consensus estimate for 2024 and 2025 earnings has moved 2 cents and 3 cents north, respectively, in the past 30 days. The stock has gained 36.8% year to date.Unum Group: Chattanooga, TN-based Unum Group provides long-term care insurance, life insurance, employer- and employee-paid group benefits and related services. This Zacks Rank #3 insurer is poised to grow on the operational excellence of Unum U.S. and Colonial Life.Encouraging sales trends, strong persistence in group lines and growth of new product lines like dental and vision, coupled with favorable risk results, should benefit Unum U.S. and Colonial Life, the two largest operating segments. It has an impressive dividend track record, with 15 dividend hikes in the last 14 years and yields better than the industry. It estimates a 10-15% increase in dividends going forward.Management estimates sales growth of 5-10% and premium growth of 5-7% in 2024 at Unum U.S. It expects sales growth in the range of 8-12% and premium growth in the band of 2-4% at Colonial Life for 2024.The expected long-term earnings growth rate for Unum Group is 8%. The Zacks Consensus Estimate for 2024 and 2025 earnings indicates a year-over-year increase of 10.7% and 5.1%, respectively. UNM delivered a trailing four-quarter earnings surprise of 2.96%, on average. The consensus estimate for 2024 and 2025 earnings has moved 1.3% and 0.6% north, respectively, in the past 60 days. The stock has gained 30.2% year to date.Trupanion: Headquartered in Seattle, WA, Trupanion is a provider of insurance for cats and dogs in the United States, Canada, Continental Europe and Australia. It operates in a total addressable market worth $34.1 billion, which is a large but underpenetrated market.This Zacks Rank #3 pet insurer is well-poised to grow, courtesy of its heightened focus on pets’ health and well-being in an underpenetrated pet insurance market, product launches, extended operating boundaries and a solid capital position. This pet insurer continues to invest in areas where it believes it can achieve high internal rates of return. Improving pricing should add to the upside.The Zacks Consensus Estimate for 2024 and 2025 earnings indicates a 68.5% and 87.2% year-over-year increase, respectively. TRUP delivered a trailing four-quarter earnings surprise of 43.13%, on average. The consensus estimate for 2024 and 2025 earnings has improved 3 cents and 1 cent, respectively, in the past 30 days. The stock has gained 35% year to date.Why Haven't You Looked at Zacks' Top Stocks?Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.Today you can access their live picks without cost or obligation.See Stocks Free >>Media ContactZacks Investment Research800-767-3771 ext. 9339support@zacks.comhttps://www.zacks.comPast performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Aflac Incorporated (AFL): Free Stock Analysis Report Unum Group (UNM): Free Stock Analysis Report Trupanion, Inc. (TRUP): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Aflac
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Aflac
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Aflac Inc
Analysen zu Aflac Inc
Datum | Rating | Analyst | |
---|---|---|---|
21.03.2018 | Aflac Equal Weight | Barclays Capital | |
03.07.2017 | Aflac Equal Weight | Barclays Capital | |
01.05.2017 | Aflac Underperform | RBC Capital Markets | |
02.02.2017 | Aflac Underperform | RBC Capital Markets | |
09.12.2016 | Aflac Underperform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
16.05.2012 | Aflac outperform | RBC Capital Markets | |
14.05.2012 | Aflac overweight | Barclays Capital | |
27.04.2012 | Aflac sector outperform | Scotia Capital Markets | |
26.04.2012 | Aflac outperform | RBC Capital Markets | |
27.03.2012 | Aflac overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
21.03.2018 | Aflac Equal Weight | Barclays Capital | |
03.07.2017 | Aflac Equal Weight | Barclays Capital | |
10.05.2016 | Aflac Mkt Perform | FBR Capital | |
27.04.2016 | Aflac Neutral | UBS AG | |
27.04.2016 | Aflac Sector Perform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
01.05.2017 | Aflac Underperform | RBC Capital Markets | |
02.02.2017 | Aflac Underperform | RBC Capital Markets | |
09.12.2016 | Aflac Underperform | RBC Capital Markets | |
09.01.2012 | Aflac sell | UBS AG |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Aflac Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen